AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 271 min read$CSX

Williams Angela C sold $1.6M of CSX

Williams Angela C (VP & Chief Accounting Officer) sold 30,000 shares of CSX CORP (CSX) at $53.29 ($1.60M total) on 2026-07-24.

Original reporting
SEC EDGAR · Williams Angela C
Published Jul 27, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CSX
Neutral
medium confidence
Mentioned
$CSX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSXNeutralLow
01

Why it matters

The disclosed sale size is moderate for a large-cap, and the filing does not provide any new operational or financial information that would change valuation assumptions.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a durable repricing without accompanying fundamental news.

03

What to watch

The filing does not state motivations, tax planning, or whether other related transactions occurred around the same period.

Relevance 6/10Novelty 3/10Timing: Filed 2026-07-27, disclosing a sale executed 2026-07-24.

Background

The article is an SEC Form 4 insider transaction disclosure for CSX, reported by VP and Chief Accounting Officer Angela C. Williams.

Company-level read

Ticker impact

$CSXNeutralMedium confidence
Context

CSX insider Angela C. Williams sold 30,000 shares at $53.2900 on 2026-07-24, totaling about $1.60M, per Form 4.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-driven and typically short-lived.

Evidence & confidence

Form 4 provides transaction mechanics and timing, but the filing does not include earnings, guidance, legal/regulatory developments, or operational changes.

Market effects

Sector

No clear sector read-through; this is company-specific insider transaction data.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Absence of a stated 10b5-1 plan could raise scrutiny, but insider sales are often driven by diversification or personal liquidity needs.

Key entities

  • public_company
    CSX

    Issuer of the Form 4 insider transaction disclosed in the article.

  • insider
    Angela C. Williams

    VP and Chief Accounting Officer who sold 30,000 CSX shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CSX insider trading history →

Related articles

SEP 17
$NSCMedAI 8/10

Rail Merger Faces More Headwinds As Port Of Mobile Objects

The $85B merger between Union Pacific (UNP) and Norfolk Southern (NSC) faces delays and opposition. The Port of Mobile, citing potential economic harm, plans to submit comments. Rival railroads (BNSF, CSX, CPKC) object to repeated data corrections in the merger proposal, calling for a halt to further changes.

waterwaysjournal.net2 min
SEP 10
$CSXMed

BNSF, CPKC, and CSX to request broad access to a combined UP

BNSF, CPKC, and CSX plan to request extensive trackage rights over a combined Union Pacific-Norfolk Southern system, if regulators approve their $85 billion merger. The railroads argue the merger will harm competition and the economy. BNSF seeks 824 miles of trackage rights between Chicago and Pennsylvania, while CPKC targets the Kansas City-St. Louis corridor and other routes. CSX also aims for access to the Kansas City-St. Louis trackage.

trains.com2 min
SEP 6
$CSXMed

CSX (CSX) Earnings Beat Leaves Its Valuation Question Open

CSX reported Q2 FY2026 earnings exceeding Wall Street estimates, with revenue and adjusted EPS above expectations. Shares have seen a 90-day return of 4.88% and a YTD return of 36.23%. The stock's fair value is estimated at $52.85, slightly above its last close of $49.41, with a P/E ratio of 28.4x, leaving valuation debates open.

simplywall.st2 min
SEP 5
$AAPLHighAI 8/10

Why Did AAPL, QTTB, CSX Stocks Surge To 52-Week Highs Today?

Apple (AAPL), Q32 Bio (QTTB), and CSX Corp. (CSX) reached 52-week highs. AAPL rose 0.6% to $323.45; Citi raised its target to $365. QTTB surged 90% after positive clinical data; Wells Fargo upgraded it to 'Overweight' with a $66 target. CSX gained 0.4% to $49.90; Raymond James lifted its target to $56. Year-to-date gains: AAPL +16%, CSX +36%, QTTB +543%.

stocktwits.com2 min
AUG 27
$CSXMedAI 8/10

Bank of America Securities Remains a Buy on CSX (CSX)

Bank of America Securities maintained a Buy rating on CSX with a $56 price target. Wells Fargo also recommended Buy, while Bernstein advised Hold. CSX reported Q2 revenue of $3.94B and net profit of $1B, up from last year. Insider sentiment is negative, with increased selling activity.

theglobeandmail.com2 min